首页> 外文期刊>Journal of Muscle Research and Cell Motility >Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro
【24h】

Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro

机译:心肌肌球蛋白结合蛋白C的N端区域的体外致病特性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Cardiac myosin binding protein-C (cMyBP-C) plays a role in sarcomeric structure and stability, as well as modulating heart muscle contraction. The 150 kDa full-length (FL) cMyBP-C has been shown to undergo proteolytic cleavage during ischemia-reperfusion injury, producing an N-terminal 40 kDa fragment (mass 29 kDa) that is predominantly associated with post-ischemic contractile dysfunction. Thus far, the pathogenic properties of such truncated cMyBP-C proteins have not been elucidated. In the present study, we hypothesized that the presence of these 40 kDa fragments is toxic to cardiomyocytes, compared to the 110 kDa C-terminal fragment and FL cMyBP-C. To test this hypothesis, we infected neonatal rat ventricular cardiomyocytes and adult rabbit ventricular cardiomyocytes with adenoviruses expressing the FL, 110 and 40 kDa fragments of cMyBP-C, and measured cytotoxicity, Ca 2+ transients, contractility, and protein-protein interactions. Here we show that expression of 40 kDa fragments in neonatal rat ventricular cardiomyocytes significantly increases LDH release and caspase 3 activity, significantly reduces cell viability, and impairs Ca 2+ handling. Adult cardiomyocytes expressing 40 kDa fragments exhibited similar impairment of Ca 2+ handling along with a significant reduction of sarcomere length shortening, relaxation velocity, and contraction velocity. Pull-down assays using recombinant proteins showed that the 40 kDa fragment binds significantly to sarcomeric actin, comparable to C0-C2 domains. In addition, we discovered several acetylation sites within the 40 kDa fragment that could potentially affect actomyosin function. Altogether, our data demonstrate that the 40 kDa cleavage fragments of cMyBP-C are toxic to cardiomyocytes and significantly impair contractility and Ca 2+ handling via inhibition of actomyosin function. By elucidating the deleterious effects of endogenously expressed cMyBP-C N-terminal fragments on sarcomere function, these data contribute to the understanding of contractile dysfunction following myocardial injury.
机译:心肌肌球蛋白结合蛋白-C(cMyBP-C)在肌节结构和稳定性以及调节心肌收缩中起作用。 150 kDa全长(FL)cMyBP-C已显示在缺血再灌注损伤期间发生蛋白水解裂解,产生N端40 kDa片段(质量为29 kDa),主要与缺血后收缩功能障碍有关。迄今为止,尚未阐明此类截短的cMyBP-C蛋白的致病性。在本研究中,我们假设与110 kDa C端片段和FL cMyBP-C相比,这些40 kDa片段的存在对心肌细胞有毒性。为了验证这一假设,我们用表达cMyBP-C的FL,110和40 kDa片段的腺病毒感染了新生大鼠心室心肌细胞和成年兔心室心肌细胞,并测量了细胞毒性,Ca 2+瞬变,收缩性和蛋白质相互作用。在这里,我们显示新生大鼠心室心肌细胞中40 kDa片段的表达显着增加LDH释放和caspase 3活性,显着降低细胞活力,并损害Ca 2+处理。表达40 kDa片段的成年心肌细胞显示出类似的Ca 2+处理损伤,以及肌节长度缩短,松弛速度和收缩速度的显着降低。使用重组蛋白进行的拉下分析显示,与C0-C2结构域相比,40 kDa片段与肌节肌动蛋白显着结合。此外,我们在40 kDa片段中发现了几个乙酰化位点,这些位点可能会影响肌动球蛋白的功能。总而言之,我们的数据表明cMyBP-C的40 kDa裂解片段对心肌细胞有毒性,并通过抑制放线菌素功能而显着损害收缩力和Ca 2+处理。通过阐明内源表达的cMyBP-C N末端片段对肌节功能的有害影响,这些数据有助于理解心肌损伤后的收缩功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号